West Pharmaceutical CEO Plans Exit after 11 Years, Succession Process Underway.
Share this article
Corporate
Score 45
Neutral
West Pharmaceutical CEO Plans Exit after 11 Years, Succession Process Underway
Mar 26, 2026 05:02 UTC
WST, CL=F, ^VIX
Medium term
Related Articles
Score 65
Netflix Executes Second Price Hike in Under 12 Months Amid Resilient Subscriber Demand
Mar 27, 15:23
Score 25
Crown Holdings appoints John M Rost as EVP and COO
Mar 27, 15:20
Score 65
Bullish
BofA Raises its Price Target on Franco-Nevada (FNV) to $311 from $280
Mar 27, 15:14
Score 35
Bullish
Citi Raises its Price Target on The New York Times (NYT) to $94
Mar 27, 15:13
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.